{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:26:43Z","timestamp":1790400403771,"version":"4.1.0"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,1]]},"DOI":"10.1097\/qai.0b013e318289bced","type":"journal-article","created":{"date-parts":[[2013,2,8]],"date-time":"2013-02-08T08:06:35Z","timestamp":1360310795000},"page":"272-279","source":"Crossref","is-referenced-by-count":43,"title":["Persisting Inflammation and Chronic Immune Activation but Intact Cognitive Function in HIV-Infected Patients After Long-Term Treatment With Combination Antiretroviral Therapy"],"prefix":"10.1097","volume":"63","author":[{"given":"Karin K.","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Gaardbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Ronit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.","family":"Hartling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle","family":"Bruunsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gerstoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Ullum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne D.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210131","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2004.08.042","article-title":"HIV dementia: an evolving disease.","volume":"157","author":"McArthur","year":"2004","journal-title":"J Neuroimmunol"},{"key":"R2-3-20210131","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/cid\/ciq041","article-title":". Incidence and impact on mortality of severe neurocognitive disorders in persons with and without HIV infection: a Danish nationwide cohort study.","volume":"52","author":"Lescure","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R3-3-20210131","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":". Updated research nosology for HIV-associated neurocognitive disorders.","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"key":"R4-3-20210131","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/13550280490521078","article-title":"Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infectedacquired immunodeficiency syndrome (HIVAIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.","volume":"10","author":"Cysique","year":"2004","journal-title":"J Neurovirol"},{"key":"R5-3-20210131","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/QAD.0b013e32828e4e27","article-title":". The prevalence and incidence of neurocognitive impairment in the HAART era.","volume":"21","author":"Robertson","year":"2007","journal-title":"AIDS"},{"key":"R6-3-20210131","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s10461-010-9836-3","article-title":". Challenges in addressing depression in HIV research: assessment, cultural context, and methods.","volume":"15","author":"Simoni","year":"2010","journal-title":"AIDS Behav"},{"key":"R7-3-20210131","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":". HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"key":"R8-3-20210131","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2217\/hiv.10.23","article-title":". Comparison of scales to evaluate the progression of HIV-associated neurocognitive disorder.","volume":"4","author":"Gandhi","year":"2010","journal-title":"HIV Ther"},{"key":"R10-3-20210131","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09540260701877894","article-title":"Neurocognitive disturbances in HIV.","volume":"20","author":"Grant","year":"2008","journal-title":"Int Rev Psychiatry"},{"key":"R11-3-20210131","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13550280590952790","article-title":". Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort.","volume":"11","author":"Tozzi","year":"2005","journal-title":"J Neurovirol"},{"key":"R12-3-20210131","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1212\/01.WNL.0000115177.74976.6C","article-title":". Neuropsychiatric impact of hepatitis C on advanced HIV.","volume":"62","author":"Ryan","year":"2004","journal-title":"Neurology"},{"key":"R13-3-20210131","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/WNL.52.3.607","article-title":". Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy.","volume":"52","author":"Childs","year":"1999","journal-title":"Neurology"},{"key":"R14-3-20210131","doi-asserted-by":"crossref","first-page":"F65","DOI":"10.1097\/00002030-199808000-00002","article-title":". Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function.","volume":"12","author":"Ferrando","year":"1998","journal-title":"AIDS"},{"key":"R15-3-20210131","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1089\/aid.2007.0310","article-title":". Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients.","volume":"24","author":"Munoz-Moreno","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R16-3-20210131","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/QAD.0b013e32834a40cd","article-title":". CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy.","volume":"25","author":"Ellis","year":"2011","journal-title":"AIDS"},{"key":"R17-3-20210131","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","article-title":". HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.","volume":"17","author":"Heaton","year":"2011","journal-title":"J Neurovirol"},{"key":"R18-3-20210131","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/QAD.0b013e3283471d10","article-title":". Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4 cell count.","volume":"25","author":"Marchetti","year":"2011","journal-title":"AIDS"},{"key":"R19-3-20210131","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/314660","article-title":". Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.","volume":"179","author":"Giorgi","year":"1999","journal-title":"J Infect Dis"},{"key":"R20-3-20210131","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":". Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"R21-3-20210131","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/374786","article-title":". T cell activation is associated with lower CD4 T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.","volume":"187","author":"Hunt","year":"2003","journal-title":"J Infect Dis"},{"key":"R22-3-20210131","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1097\/00002030-200309050-00006","article-title":". Persistent immune activation in HIV-1 infection is associated with progression to AIDS.","volume":"17","author":"Hazenberg","year":"2003","journal-title":"AIDS"},{"key":"R23-3-20210131","doi-asserted-by":"crossref","first-page":"a3172","DOI":"10.1136\/bmj.a3172","article-title":"HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.","volume":"338","author":"Deeks","year":"2009","journal-title":"BMJ"},{"key":"R24-3-20210131","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1097\/QAD.0b013e3283174636","article-title":"The role of HIV in serious diseases other than AIDS.","volume":"22","author":"Phillips","year":"2008","journal-title":"AIDS"},{"key":"R25-3-20210131","doi-asserted-by":"crossref","first-page":"M357","DOI":"10.1093\/gerona\/54.7.M357","article-title":". A high plasma concentration of TNF-alpha is associated with dementia in centenarians.","volume":"54","author":"Bruunsgaard","year":"1999","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R26-3-20210131","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.neurobiolaging.2007.08.013","article-title":". Genetic priming of a proinflammatory profile predicts low IQ in octogenarians.","volume":"30","author":"Krabbe","year":"2009","journal-title":"Neurobiol Aging"},{"key":"R27-3-20210131","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1532-5415.2007.01159.x","article-title":". Systemic markers of inflammation and cognitive decline in old age.","volume":"55","author":"Schram","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"R28-3-20210131","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archneur.61.5.668","article-title":". Inflammatory proteins in plasma and the risk of dementia: the rotterdam study.","volume":"61","author":"Engelhart","year":"2004","journal-title":"Arch Neurol"},{"key":"R29-3-20210131","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.59.3.371","article-title":". Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging.","volume":"59","author":"Weaver","year":"2002","journal-title":"Neurology"},{"key":"R30-3-20210131","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":". Systemic inflammation and disease progression in Alzheimer disease.","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurology"},{"key":"R31-3-20210131","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1212\/01.WNL.0000145763.68284.15","article-title":". Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.","volume":"63","author":"Sevigny","year":"2004","journal-title":"Neurology"},{"key":"R32-3-20210131","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/prca.200900083","article-title":". Biomarkers of neurological status in HIV infection: a 3-year study.","volume":"4","author":"Ragin","year":"2010","journal-title":"Proteomics Clin Appl"},{"key":"R33-3-20210131","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/QAI.0b013e3182237e54","article-title":". Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection.","volume":"57","author":"Lyons","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R34-3-20210131","doi-asserted-by":"crossref","first-page":"e2516","DOI":"10.1371\/journal.pone.0002516","article-title":". Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients.","volume":"3","author":"Ancuta","year":"2008","journal-title":"PLoS One"},{"key":"R35-3-20210131","doi-asserted-by":"crossref","first-page":"e51132","DOI":"10.1371\/journal.pone.0051132","article-title":". Cognitive functions in middle aged individuals are related to metabolic disturbances and aerobic capacity: a cross-sectional study.","volume":"7","author":"Pedersen","year":"2012","journal-title":"PLoS One"},{"key":"R36-3-20210131","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":". Validation of a combined comorbidity index.","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"R37-3-20210131","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":". A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R38-3-20210131","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-0327(00)00309-8","article-title":". The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity.","volume":"66","author":"Bech","year":"2001","journal-title":"J Affect Disord"},{"issue":"pt 3","key":"R42-3-20210131","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.2044-8260.1992.tb00999.x","article-title":"Verbal fluency: a NART-based equation for the estimation of premorbid performance.","volume":"31","author":"Crawford","year":"1992","journal-title":"Br J Clin Psychol"},{"key":"R43-3-20210131","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/arclin\/12.8.711","article-title":"Methods of estimating premorbid functioning.","volume":"12","author":"Franzen","year":"1997","journal-title":"Arch Clin Neuropsychol"},{"key":"R44-3-20210131","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/QAD.0b013e3280ef6acd","article-title":". HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.","volume":"21","author":"McCutchan","year":"2007","journal-title":"AIDS"},{"key":"R45-3-20210131","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1468-1293.2008.00679.x","article-title":". Neurocognitive screening tools in HIVAIDS: comparative performance among patients exposed to antiretroviral therapy.","volume":"10","author":"Skinner","year":"2009","journal-title":"HIV Med"},{"key":"R46-3-20210131","first-page":"356","article-title":"The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence BMC Infect Dis.","volume":"11","author":"Gisslen","year":"2011","journal-title":""},{"key":"R47-3-20210131","first-page":"138","article-title":"Cesana BM, et al..","volume":"9","author":"Torti","year":"2011","journal-title":"Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction BMC Med"},{"key":"R48-3-20210131","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1310\/hct1206-333","article-title":"Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy.","volume":"12","author":"Garvey","year":"2011","journal-title":"HIV Clin Trials"},{"key":"R49-3-20210131","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/13548506.2011.579990","article-title":". HIV and depression-a systematic review of interventions.","volume":"16","author":"Sherr","year":"2011","journal-title":"Psychol Health Med"},{"key":"R50-3-20210131","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/QAI.0B013E31822D490A","article-title":". Depression and HIVAIDS treatment nonadherence: a review and meta-analysis.","volume":"58","author":"Gonzalez","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R51-3-20210131","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11904-008-0025-1","article-title":"HIV and depression: 2008 review and update.","volume":"5","author":"Rabkin","year":"2008","journal-title":"Curr HIVAIDS Rep"},{"key":"R52-3-20210131","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11920-008-0045-y","article-title":"Depression and HIVAIDS.","volume":"10","author":"Benton","year":"2008","journal-title":"Curr Psychiatry Rep"},{"key":"R53-3-20210131","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/WCO.0b013e32834695fb","article-title":"Current understanding of HIV-associated neurocognitive disorders pathogenesis.","volume":"24","author":"Gannon","year":"2011","journal-title":"Curr Opin Neurol"},{"key":"R54-3-20210131","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1126\/science.277.5322.112","article-title":". Positive effects of combined antiretroviral therapy on CD4 T cell homeostasis and function in advanced HIV disease.","volume":"277","author":"Autran","year":"1997","journal-title":"Science"},{"key":"R55-3-20210131","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00002030-199205000-00004","article-title":". Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment.","volume":"6","author":"Brew","year":"1992","journal-title":"AIDS"},{"key":"R56-3-20210131","first-page":"118","article-title":"Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy.","volume":"17","author":"Deeks","year":"2009","journal-title":"Top HIV Med"},{"key":"R57-3-20210131","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/25374","article-title":". Changes in thymic function with age and during the treatment of HIV infection.","volume":"396","author":"Douek","year":"1998","journal-title":"Nature"},{"key":"R58-3-20210131","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1182\/blood.V95.1.249","article-title":". T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).","volume":"95","author":"Hazenberg","year":"2000","journal-title":"Blood"},{"key":"R59-3-20210131","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1086\/340418","article-title":". Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.","volume":"185","author":"Kolte","year":"2002","journal-title":"J Infect Dis"},{"key":"R60-3-20210131","first-page":"2","article-title":"Pathogenesis of HIV infection: total CD4 T-cell pool, immune activation, and inflammation.","volume":"18","author":"Lane","year":"2010","journal-title":"Top HIV Med"},{"key":"R61-3-20210131","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":". Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection.","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"key":"R62-3-20210131","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00002030-200303070-00007","article-title":". Impaired production of cytokines is an independent predictor of mortality in HIV-1-infected patients.","volume":"17","author":"Ostrowski","year":"2003","journal-title":"AIDS"},{"key":"R63-3-20210131","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1182\/blood.V96.13.4091","article-title":". Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection.","volume":"96","author":"Sidenius","year":"2000","journal-title":"Blood"},{"key":"R64-3-20210131","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/QAD.0b013e32832c4152","article-title":". Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance.","volume":"23","author":"Marra","year":"2009","journal-title":"AIDS"},{"key":"R65-3-20210131","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ana.20198","article-title":". Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders.","volume":"56","author":"Letendre","year":"2004","journal-title":"Ann Neurol"},{"key":"R66-3-20210131","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archneur.59.6.923","article-title":". Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.","volume":"59","author":"Ellis","year":"2002","journal-title":"Arch Neurol"},{"key":"R67-3-20210131","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1212\/01.WNL.0000058768.73358.1A","article-title":". Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy.","volume":"60","author":"Marra","year":"2003","journal-title":"Neurology"},{"key":"R68-3-20210131","first-page":"45","article-title":". Neurologic complications of HIV disease and their treatment.","volume":"18","author":"Letendre","year":"2010","journal-title":"Top HIV Med"},{"key":"R69-3-20210131","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/13550280902973960","article-title":". Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy.","volume":"15","author":"Cardenas","year":"2009","journal-title":"J Neurovirol"},{"key":"R70-3-20210131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archneur.64.1.97","article-title":". An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection.","volume":"64","author":"Sevigny","year":"2007","journal-title":"Arch Neurol"},{"key":"R71-3-20210131","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11065-009-9102-5","article-title":". Cognitive neuropsychology of HIV-associated neurocognitive disorders.","volume":"19","author":"Woods","year":"2009","journal-title":"Neuropsychol Rev"},{"key":"R72-3-20210131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1468-1293.2012.01043.x","article-title":". Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care.","volume":"14","author":"McCombe","year":"2012","journal-title":"HIV Med"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0b013e318289bced","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:59:23Z","timestamp":1620971963000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201307010-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,1]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318289bced","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7,1]]}}}